300 related articles for article (PubMed ID: 16585475)
21. Serum testosterone and bioavailable testosterone correlate with age and body size in hypogonadal men treated with testosterone undecanoate (1000 mg IM--Nebido).
Moisey R; Swinburne J; Orme S
Clin Endocrinol (Oxf); 2008 Oct; 69(4):642-7. PubMed ID: 18394021
[TBL] [Abstract][Full Text] [Related]
22. Leuprolide acetate suppresses pedophilic urges and arousability.
Schober JM; Kuhn PJ; Kovacs PG; Earle JH; Byrne PM; Fries RA
Arch Sex Behav; 2005 Dec; 34(6):691-705. PubMed ID: 16362253
[TBL] [Abstract][Full Text] [Related]
23. Androgen replacement with oral testosterone undecanoate in hypogonadal men: a double blind controlled study.
Skakkebaek NE; Bancroft J; Davidson DW; Warner P
Clin Endocrinol (Oxf); 1981 Jan; 14(1):49-61. PubMed ID: 7014044
[TBL] [Abstract][Full Text] [Related]
24. Testosterone replacement therapy outcomes among opioid users: the Testim Registry in the United States (TRiUS).
Blick G; Khera M; Bhattacharya RK; Nguyen D; Kushner H; Miner MM
Pain Med; 2012 May; 13(5):688-98. PubMed ID: 22536837
[TBL] [Abstract][Full Text] [Related]
25. Effects of endogenous testosterone and estradiol on sexual behavior in normal young men.
Bagatell CJ; Heiman JR; Rivier JE; Bremner WJ
J Clin Endocrinol Metab; 1994 Mar; 78(3):711-6. PubMed ID: 8126146
[TBL] [Abstract][Full Text] [Related]
26. Treatment of hypogonadism in men with chronic kidney disease.
Johansen KL
Adv Chronic Kidney Dis; 2004 Oct; 11(4):348-56. PubMed ID: 15492971
[TBL] [Abstract][Full Text] [Related]
27. Effects of androgen on sexual behavior in hypogonadal men.
Davidson JM; Camargo CA; Smith ER
J Clin Endocrinol Metab; 1979 Jun; 48(6):955-8. PubMed ID: 447801
[TBL] [Abstract][Full Text] [Related]
28. Long-term efficacy and safety of a permeation-enhanced testosterone transdermal system in hypogonadal men.
Arver S; Dobs AS; Meikle AW; Caramelli KE; Rajaram L; Sanders SW; Mazer NA
Clin Endocrinol (Oxf); 1997 Dec; 47(6):727-37. PubMed ID: 9497881
[TBL] [Abstract][Full Text] [Related]
29. The effects of oral contraceptives on androgen levels and their relevance to premenstrual mood and sexual interest: a comparison of two triphasic formulations containing norgestimate and either 35 or 25 microg of ethinyl estradiol.
Greco T; Graham CA; Bancroft J; Tanner A; Doll HA
Contraception; 2007 Jul; 76(1):8-17. PubMed ID: 17586130
[TBL] [Abstract][Full Text] [Related]
30. Testosterone patch for the treatment of hypoactive sexual desire disorder in naturally menopausal women: results from the INTIMATE NM1 Study.
Shifren JL; Davis SR; Moreau M; Waldbaum A; Bouchard C; DeRogatis L; Derzko C; Bearnson P; Kakos N; O'Neill S; Levine S; Wekselman K; Buch A; Rodenberg C; Kroll R
Menopause; 2006; 13(5):770-9. PubMed ID: 16932240
[TBL] [Abstract][Full Text] [Related]
31. Plasma levels of dihydrotestosterone remain in the normal range in men treated with long-acting parenteral testosterone undecanoate.
Yassin AA; Saad F
Andrologia; 2007 Oct; 39(5):181-4. PubMed ID: 17714216
[TBL] [Abstract][Full Text] [Related]
32. The impact of hypogonadism and autonomic dysfunction on fatigue, emotional function, and sexual desire in male patients with advanced cancer: a pilot study.
Strasser F; Palmer JL; Schover LR; Yusuf SW; Pisters K; Vassilopoulou-Sellin R; DeGracia B; Willey JS; Bruera E
Cancer; 2006 Dec; 107(12):2949-57. PubMed ID: 17103445
[TBL] [Abstract][Full Text] [Related]
33. Urine and Serum Sex Steroid Profile in Testosterone-Treated Transgender and Hypogonadal and Healthy Control Men.
Savkovic S; Lim S; Jayadev V; Conway A; Turner L; Curtis D; Goebel C; Handelsman DJ
J Clin Endocrinol Metab; 2018 Jun; 103(6):2277-2283. PubMed ID: 29584875
[TBL] [Abstract][Full Text] [Related]
34. Effects of testosterone and nandrolone on cardiac function: a randomized, placebo-controlled study.
Chung T; Kelleher S; Liu PY; Conway AJ; Kritharides L; Handelsman DJ
Clin Endocrinol (Oxf); 2007 Feb; 66(2):235-45. PubMed ID: 17223994
[TBL] [Abstract][Full Text] [Related]
35. Sex steroids, precursors, and metabolite deficiencies in men with isolated hypogonadotropic hypogonadism and panhypopituitarism: a GCMS-based comparative study.
Giton F; Trabado S; Maione L; Sarfati J; Le Bouc Y; Brailly-Tabard S; Fiet J; Young J
J Clin Endocrinol Metab; 2015 Feb; 100(2):E292-6. PubMed ID: 25393641
[TBL] [Abstract][Full Text] [Related]
36. Effects of testosterone replacement in androgen-deficient women with hypopituitarism: a randomized, double-blind, placebo-controlled study.
Miller KK; Biller BM; Beauregard C; Lipman JG; Jones J; Schoenfeld D; Sherman JC; Swearingen B; Loeffler J; Klibanski A
J Clin Endocrinol Metab; 2006 May; 91(5):1683-90. PubMed ID: 16478814
[TBL] [Abstract][Full Text] [Related]
37. Efficacy of changing testosterone gel preparations (Androgel or Testim) among suboptimally responsive hypogonadal men.
Grober ED; Khera M; Soni SD; Espinoza MG; Lipshultz LI
Int J Impot Res; 2008; 20(2):213-7. PubMed ID: 17898800
[TBL] [Abstract][Full Text] [Related]
38. Improvement of sexual function in testosterone deficient men treated for 1 year with a permeation enhanced testosterone transdermal system.
Arver S; Dobs AS; Meikle AW; Allen RP; Sanders SW; Mazer NA
J Urol; 1996 May; 155(5):1604-8. PubMed ID: 8627833
[TBL] [Abstract][Full Text] [Related]
39. Effect of gonadotropin-releasing-hormone-induced hypogonadism on insulin action as assessed by euglycemic clamp studies in men.
Chauhan S; Diamond MP
Fertil Steril; 2005 Jul; 84(1):186-90. PubMed ID: 16009176
[TBL] [Abstract][Full Text] [Related]
40. Effects of aromatase inhibition on sexual function and well-being in postmenopausal women treated with testosterone: a randomized, placebo-controlled trial.
Davis SR; Goldstat R; Papalia MA; Shah S; Kulkarni J; Donath S; Bell RJ
Menopause; 2006; 13(1):37-45. PubMed ID: 16607097
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
